Insilico Medicine Announces Global R&D Collaboration with Lilly
AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas.CAMBRIDGE, Mass., March 29, 2026...
Read moreDetails